Taxotere Lawsuit Lawyer: MDL 2740 Status, Verdicts and How to Choose Counsel
A taxotere lawsuit lawyer helps people who believe the breast cancer drug Taxotere (docetaxel) caused them permanent hair loss, a condition doctors call permanent alopecia. Most chemotherapy hair loss grows back. Some former patients say theirs never did, and thousands of them sued Sanofi, the company that makes Taxotere. Their federal cases were combined into one large court proceeding in New Orleans. This guide explains what that litigation is, where it stands as of November 2026, what the court records show about trials and case numbers, and what a lawyer in this area actually does. It also covers deadlines, fees, and how to check a lawyer before you hire one. This article is general information only. It is not legal or medical advice, and only a licensed attorney can review the facts of a specific claim.
| Quick Fact | Details |
|---|---|
| Drug | Taxotere (docetaxel), a chemotherapy drug made by Sanofi; generic versions also exist |
| Main injury claimed | Permanent alopecia (hair loss that does not grow back) |
| Federal case | MDL No. 2740, In re: Taxotere (Docetaxel) Products Liability Litigation |
| Court | U.S. District Court for the Eastern District of Louisiana |
| Judge | Jane Triche Milazzo |
| FDA label update | Approved December 11, 2015, adding that cases of permanent alopecia have been reported |
| Bellwether trials | Two, in 2019 and 2021, both ended in verdicts for Sanofi |
| Cases pending | 136 as of the August 3, 2026 federal report, out of 15,572 filed over the life of the MDL |
What Is the Taxotere Lawsuit About?
The Taxotere lawsuits claim that Sanofi did not warn doctors and patients clearly enough that the drug could cause hair loss that never grows back. Plaintiffs say that if they had known, they might have chosen a different chemotherapy drug.
Taxotere is used to treat several cancers, including breast cancer. Temporary hair loss is a well-known side effect of chemotherapy. The lawsuits focus on something different: hair that did not return months or years after treatment ended. Many plaintiffs describe the emotional toll of living with a constant, visible reminder of cancer.
Sanofi has denied the claims. Its defense has included arguments that the label gave adequate warnings, that federal drug rules limited what it could change on its own, and that other factors could explain a plaintiff’s hair loss. Companies that sold generic docetaxel were also named in many cases.
When Did the FDA Add a Permanent Hair Loss Warning?
The FDA approved a Taxotere label change on December 11, 2015. The updated label states that “cases of permanent alopecia have been reported.”
According to the FDA approval package for the 2015 Taxotere supplement, Sanofi submitted the change on November 24, 2015. The new wording went into the postmarketing experience section, the patient counseling section, and the patient information leaflet. A 2024 federal appeals court opinion describes the background: the FDA asked Sanofi for data on permanent alopecia in March 2015 and asked for a label update in October 2015.
This date matters in the lawsuits. People treated before the change argue they were never warned. The date can also affect when a person “should have known” about a possible link, which ties into filing deadlines.
What Is MDL No. 2740?
MDL No. 2740 is the federal multidistrict litigation that gathers Taxotere hair loss cases from across the country before one judge in New Orleans. It was created in 2016 and is overseen by Judge Jane Triche Milazzo.
An MDL is not a class action. Each person keeps an individual lawsuit. The cases are grouped so that one judge can handle shared issues, such as evidence exchange and expert witness rulings, in one place. When that work is done, cases may settle, be dismissed, or be sent back to their home courts for trial.
A second, separate MDL, No. 3023, covers claims that docetaxel caused eye injuries such as excessive tearing. The same judge oversees both.
| Item | MDL No. 2740 (hair loss) | MDL No. 3023 (eye injury) |
|---|---|---|
| Main claim | Permanent alopecia | Excessive tearing and tear duct damage |
| Court | E.D. Louisiana | E.D. Louisiana |
| Judge | Jane Triche Milazzo | Jane Triche Milazzo |
| Created | 2016 | 2022 |
| Pending cases (Aug. 3, 2026) | 136 | 141 |
| Total cases filed (history) | 15,572 | 433 |
How Many Taxotere Cases Are Still Pending?
Very few hair loss cases remain. The federal Judicial Panel on Multidistrict Litigation report dated August 3, 2026 lists 136 pending actions in MDL No. 2740, out of 15,572 filed over its history.
The drop has been steep. The panel’s March 2, 2026 report listed 1,173 pending cases. Its July 1, 2026 report listed 203. The MDL still appeared on the panel’s list of pending dockets on October 1, 2026, so it had not formally closed at that point. Case counts change every month, so treat these figures as a snapshot.
What Happened at the Taxotere Bellwether Trials?
Sanofi won both bellwether trials held in the MDL. A bellwether is a test case that helps both sides see how juries react to the evidence.
The first trial, Earnest v. Sanofi, ended in a defense verdict in September 2019. Reports from the time say the jury deliberated for about two hours after a multiweek trial. The second trial, brought by plaintiff Elizabeth Kahn, ended with a jury verdict for Sanofi in November 2021, and the court entered judgment on November 22, 2021. In that case, the jury found that Sanofi had provided a sufficient warning. Kahn’s lawyer said at the time that she would appeal.
| Event | Date | Result |
|---|---|---|
| MDL No. 2740 created | 2016 | Federal hair loss cases sent to New Orleans |
| FDA label update | December 11, 2015 | Permanent alopecia added to label |
| First bellwether (Earnest) | September 2019 | Defense verdict |
| Second bellwether (Kahn) | November 2021 | Defense verdict |
| Fifth Circuit ruling (Hickey v. Hospira) | May 24, 2024 | Narrowed failure-to-warn claims against generic makers |
| Order enforcing a Sanofi settlement in 11 cases | May 14, 2026 | Those 11 cases dismissed |
Has Sanofi Settled the Taxotere Lawsuits?
No public, global settlement amount has been announced as of November 2026. However, court activity shows that at least some settlement agreements exist.
Legal news reports say that on May 14, 2026, Judge Milazzo granted Sanofi’s motion to enforce a settlement and dismissed 11 hair loss cases. The terms were not made public in those reports. Some public trackers still say no settlement has been announced, so the sources do not fully agree. What is clear is that the number of pending cases fell sharply in 2026. Court reports do not say how many cases ended through settlement versus dismissal.
Anyone who sees a “settlement amount” for Taxotere online should be careful. Without a court record or a company statement, such numbers are guesses.
What Does a Taxotere Lawsuit Lawyer Do?
A taxotere lawsuit lawyer reviews whether a claim is still possible, gathers proof, and handles the court process. In general, the work looks like this:
- Case evaluation: The lawyer checks when you took the drug, which company made the dose you received, when your hair loss began, and whether your filing deadline has passed.
- Medical and pharmacy records: Infusion records often show the manufacturer. This matters because generic docetaxel makers face different legal rules than Sanofi.
- Proof of injury: Photos taken before, during, and after treatment, plus records from doctors or dermatologists, can help show permanent hair loss.
- Court filings: In an MDL, lawyers must follow strict orders, such as fact sheets and deadlines. Missing them can lead to dismissal.
- Negotiation: If a settlement program exists, a lawyer explains the terms and your choices.
Most lawyers in drug injury cases work on a contingency fee. That means the lawyer is paid a share of any recovery and usually receives no fee if there is no recovery. Under the American Bar Association’s model ethics rules, a contingency fee agreement must be in writing and explain how the fee and costs are calculated. Ask whether case costs come out before or after the lawyer’s percentage.
Is There a Deadline to File a Taxotere Claim?
Yes. Every state has a statute of limitations for injury claims, and the clock often starts when a person knew, or should have known, about the injury and its possible cause.
These deadlines are a big reason many Taxotere cases were dismissed. The court has thrown out some cases as filed too late under state law. Louisiana, for example, long used a one-year prescriptive period for many injury claims, and its rules have since changed for newer claims. Because the FDA added the warning in December 2015, a court may decide a patient had notice years ago. A licensed attorney in your state can tell you whether any time remains.
How Do You Choose a Taxotere Lawsuit Lawyer?
Start by confirming the lawyer is licensed and in good standing. Every state bar has a public lookup tool, and the American Bar Association’s directory of state bar lawyer finders links to them.
Then ask direct questions before you sign anything:
- Have you handled drug injury cases in a federal MDL?
- Can my claim still be filed given my treatment dates?
- Will you or another firm actually work on my case?
- What percentage do you charge, and how are case costs handled?
- How often will you update me, and who do I call with questions?
Be cautious with ads that promise a set payout. No honest lawyer can promise a result, and the bellwether juries in this litigation sided with Sanofi.
If you are comparing other drug and product cases, our look at Roundup lawsuit payouts shows how settlements in another mass tort were structured. You can also browse more guides in our lawsuit category, including unusual cases such as the Pepsi fighter jet lawsuit.
Frequently Asked Questions
Can I still file a Taxotere hair loss lawsuit in 2026?
It depends on your state’s filing deadline and your treatment dates. Many claims are now likely too late, but only a licensed attorney who reviews your records can say for sure.
Who is the judge in the Taxotere MDL?
Judge Jane Triche Milazzo of the U.S. District Court for the Eastern District of Louisiana oversees both MDL No. 2740 and the eye injury MDL No. 3023.
Did anyone win a Taxotere trial?
Not in the federal bellwether trials. Juries returned verdicts for Sanofi in September 2019 and November 2021.
How much does a Taxotere lawsuit lawyer cost?
Most charge a contingency fee, which is a percentage of any recovery. The agreement should be in writing and explain how costs are handled.
What if I took a generic version of docetaxel?
Generic makers face different federal rules, and a 2024 appeals court ruling narrowed some claims against them. A lawyer will need your infusion records to identify the maker.
Conclusion
The Taxotere hair loss litigation has moved from more than 15,000 filed cases to a small number still pending as of November 2026. Sanofi won both bellwether trials, and while court records show some settlements, no public global settlement figure exists. For anyone still weighing a claim, timing is the key issue. A Taxotere lawsuit lawyer can check your treatment dates, identify the drug maker, and tell you whether your state’s deadline has passed. Before you hire anyone, confirm their license through your state bar, get the fee agreement in writing, and ask clear questions. A licensed attorney can explain your options based on your own facts.
One Comment